MENU
+Compare
GH
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$47.34
Change
+$1.70 (+3.72%)
Capitalization
2.46B

GH Guardant Health Forecast, Technical & Fundamental Analysis

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use... Show more

GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for GH with price predictions
Apr 23, 2025

GH's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for GH turned positive on April 14, 2025. Looking at past instances where GH's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 11, 2025. You may want to consider a long position or call options on GH as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

GH moved above its 50-day moving average on April 22, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for GH crossed bullishly above the 50-day moving average on April 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GH advanced for three days, in of 285 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 64 cases where GH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GH entered a downward trend on March 19, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.528) is normal, around the industry mean (23.728). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (4.021) is also within normal values, averaging (41.794).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GH is expected to report earnings to rise 20.74% to -74 cents per share on April 30

Guardant Health GH Stock Earnings Reports
Q1'25
Est.
$-0.75
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.29
Q2'24
Beat
by $0.26
Q1'24
Beat
by $0.41
The last earnings report on February 20 showed earnings per share of -62 cents, beating the estimate of -77 cents. With 839.88K shares outstanding, the current market capitalization sits at 2.46B.
A.I. Advisor
published General Information

General Information

a developer of diagnostic technologies to improve cancer management

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
3100 Hanover Street
Phone
+1 855 698-8887
Employees
1779
Web
https://www.guardanthealth.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CEMDX12.550.18
+1.46%
Cullen Emerging Markets High Div Retail
FISRX2.23N/A
N/A
Franklin Income R
FVDFX35.41N/A
N/A
Fidelity Value Discovery
EVUYX18.81N/A
N/A
Allspring Util and Telecomms Inst
STRBX17.17N/A
N/A
Sterling Capital Behav Sm Cp Val Eq R6

GH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GH has been loosely correlated with VCYT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GH jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GH
1D Price
Change %
GH100%
+4.20%
VCYT - GH
51%
Loosely correlated
+1.08%
NTRA - GH
50%
Loosely correlated
+2.72%
TWST - GH
46%
Loosely correlated
+1.84%
BLFS - GH
46%
Loosely correlated
+11.19%
GKOS - GH
41%
Loosely correlated
+3.21%
More